Front. Oncol.
Frontiers in Oncology
Front. Oncol.
2234-943X
Frontiers Media S.A.
10.3389/fonc.2026.1798299
Correction
Correction: Long-term survival of an advanced gastric cancer patient with multiple liver metastases following maintenance therapy with envafolimab and oral chemotherapy: a case report
Frontiers Production Office
*
Frontiers Media SA, Lausanne, Switzerland
Correspondence: Frontiers Production Office, production.office@frontiersin.org
10
02
2026
2026
16
1798299
28
01
2026
28
01
2026
Copyright © 2026 Frontiers Production Office.
2026
Frontiers Production Office
https://creativecommons.org/licenses/by/4.0/
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
A Correction on
Long-term survival of an advanced gastric cancer patient with multiple liver metastases following maintenance therapy with envafolimab and oral chemotherapy: a case report By Wang S, Zong H, Wu L, Wei Y and Wang H (2025) Front. Oncol. 15:1685259. doi: 10.3389/fonc.2025.1685259
advanced gastric cancer
liver metastases
immunotherapy
envafolimab
raltitrexed
maintenance therapy
long-term survival
section-at-acceptance
Gastrointestinal Cancers: Gastric and Esophageal Cancers
Affiliation “Zist Balin Co. Iran”, was erroneously given as “Sodour Ahrar Shargh Co., Iran”.
The original version of this article has been updated.
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland